Explorer les evidences

93,5 %Crude ACPRs were 93.5% for SP alone in the treatment of uncomplicated P. falciparum malaria in Mali.

Malipaludismepublié 2015Malaria journaleurope_pmcdocument de 7 observations

75 %The median coverage rate for long-lasting insecticidal net (LLIN) mass distribution for the 75 health districts and the 5 epidemic years was 75.0%.

MalipaludismeHAL · Unilimdocument de 111 observations

80 %Both microscopy and qPCR diagnostic approaches detected comparable proportions (∼80%) of all RDT-positive samples infected with the dominant P. falciparum malaria parasite.

Malipaludismeobservé 2017, 2018publié 2020The American journal of tropical medicine and hygieneeurope_pmcdocument de 6 observationsDOI 10.4269/ajtmh.20-0593

10 %Higher proportions of non-falciparum species were detected by qPCR than microscopy: 10% against 3% infections for P. malariae.

Malipaludismeobservé 2017, 2018publié 2020The American journal of tropical medicine and hygieneeurope_pmcdocument de 6 observationsDOI 10.4269/ajtmh.20-0593

1,15 %P. malariae prevalence was 1.15% in active screening.

Malipaludismepublié 2023Tropical medicine and infectious diseaseeurope_pmcdocument de 16 observations

98,66 %HemotypeSC® had a negative predictive value of 98.66% to detect sickle cell disease carrier compared to high-performance liquid chromatography.

MalidrépanocytoseHAL · Unilimdocument de 103 observations

14 %In Kilifi County, Kenya, 14% of children in the case group were girls heterozygous for G6PD c.202T.

Malidéficit en G6PDpublié 2015The Lancet. Haematologyeurope_pmcdocument de 11 observationsDOI 10.1016/s2352-3026(15)00152-0

0,82 odds_ratioG6PD c.202T heterozygous girls had significant protection from severe malaria with an odds ratio of 0.82.

Malipaludismepublié 2015The Lancet. Haematologyeurope_pmcdocument de 11 observationsDOI 10.1016/s2352-3026(15)00152-0

1 per_1000_person_weeksMalaria cases per 1,000 person-weeks peaked during the rainy season, which began in week 21 and ended in week 40.

MalipaludismeHAL · Unilimdocument de 80 observations

23,3 %The overall proportion of fever attributable to malaria parasitaemia was 23.3% during the dry season in Bandiagara district, Mali.

Malipaludismeobservé dry season of 1994publié 2005Tropical medicine & international health : TM & IHeurope_pmcdocument de 4 observationsDOI 10.1111/j.1365-3156.2005.01418.x

57 health_districts57 out of 75 health districts have been selected for Seasonal Malaria Chemoprevention (SMC) in Mali over the next 3–5 years.

Malipaludismeobservé next 3–5 yearsHAL · Unilimdocument de 95 observations

75,3 %The protective efficacy of the combination as compared with the vaccine alone was 75.3% against death from malaria.

Malipaludismepublié 2021The New England journal of medicineeurope_pmcdocument de 10 observations

96,7 %The positive predictive value of OptiMal-IT compared to thick smear microscopy was 96.7%.

Malipaludismepublié 2011Malaria journaleurope_pmcdocument de 5 observationsDOI 10.1186/1475-2875-10-345

12,1 %In the pre-COVID-19 sample group (N = 283), the prevalence of antibody responders against RBM was 12.1% among females.

MaliSARS-CoV-2 RBMHAL · Unilimdocument de 67 observations

598 casesThe reported number of COVID-19 cases in the Tombouctou population was 598.

MaliCOVID-19HAL · Unilimdocument de 88 observations

17,7 %Among 552 evaluable patients in the WANECAM trial, 17.7% had qPCR-detectable parasitemia at 72 hours during their first treatment episode.

Malipaludismepublié 2021Antimicrobial agents and chemotherapyeurope_pmcdocument de 2 observations

98,9 %To detect SCD carrier, SickleScan® had a negative predictive value (NPV) of 98.90% (95% CI: 98.51–99.29).

Malisickle cell disease carrierobservé 2021HAL · Unilimdocument de 103 observations

5,47 IRRParticipants living in households with more than one positive case had an incidence rate ratio of 5.47 for SARS-CoV-2 seropositivity.

MaliCOVID-19HAL · Unilimdocument de 88 observations

43,1 USDLe coût moyen par test antigénique rapide pour la COVID-19 était de 43,1 USD dans le bras intervention et de 1 449,2 USD dans le bras SOC.

MaliCOVID-19HAL · Unilimdocument de 36 observations

15 390 276 testsOver the 2018–2022 period, 76% (15,390,276) of suspected malaria cases in Mali were tested by rapid diagnostic test (RDT).

Malipaludismeobservé 2018–2022HAL · Unilimdocument de 111 observations

98,6 %Both RDTs had a negative predictive value greater than 98.6% for excluding sickle cell disease compared with HPLC.

MalidrépanocytoseHAL · Unilimdocument de 103 observations

58,1 %The spleen rate was 58.1% among randomly selected children in the District of Yanfolila in southern Mali.

Malipaludismepublié 2000Tropical medicine & international health : TM & IHeurope_pmcdocument de 5 observations

36 046 casAu 31 janvier 2022, 36 046 cas de COVID-19 avaient été signalés au Mali.

MaliCOVID-19observé 31 janvier 2022HAL · Unilimdocument de 36 observations

5 casesDuring the study, 5 of 68 children with conditional TCD converted to abnormal TCD.

Malidrépanocytoseobservé 2008 to 2013publié 2013BloodOpenAlexdocument de 10 observations

229 000 000 casEn 2019, selon les estimations de l’OMS, le nombre de cas de paludisme survenus s’élevait à 229 millions de cas détectés.

Malipaludismeobservé 2019HAL · Unilimdocument de 214 observations